Live from the NIH registry
Studies recruiting near Oxnard right now
Top 25 of 128 recruiting studies, sorted by proximity — each links to its official registry page
The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.
Paroxysmal Atrial Fibrillation
N/A
Observational 250 participants sought
Community Memorial Health System — Ventura, California (8.5 mi)
· Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
Hidradenitis Suppurativa
Phase 1
Interventional 24 participants sought
Clinical Trials Research Institute — Thousand Oaks, California (19.7 mi)
· Sponsor: Incyte Corporation
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Phase 3
Interventional 882 participants sought
Om Research LLC 2 — Oxnard, California (0.3 mi)
· Sponsor: Janssen Research & Development, LLC
A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II)
Lower Extremity Acute Limb Ischemia, LE ALI
N/A
Observational 300 participants sought
Community Memorial Hospital — Ventura, California (8.5 mi)
· Sponsor: Penumbra Inc.
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Psoriatic Arthritis
Phase 3
Interventional 1,182 participants sought
The Cohen Medical Centers — Thousand Oaks, California (19.7 mi)
· Sponsor: Takeda
A Study of VARIPULSE Pulsed Field Ablation (PFA) Catheter and FARAWAVE PFA Catheter in the Treatment of Participants With Persistent Atrial Fibrillation
Atrial Fibrillation
N/A
Interventional 566 participants sought
Community Memorial Hospital — Ventura, California (8.5 mi)
· Sponsor: Biosense Webster, Inc.
A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo
Vitiligo, Non-Segmental Vitiligo (NSV)
Phase 2
Interventional 66 participants sought
Cura Clinical Research - Oxnard — Oxnard, California (0.3 mi)
· Sponsor: Eli Lilly and Company
Product Surveillance Registry
Cardiac Rhythm Disorders, Urological Disorders
N/A
Observational 100,000 participants sought
Research site — Ventura, California (8.5 mi)
· Sponsor: Medtronic
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Mitral Valve Regurgitation
N/A
Interventional 1,056 participants sought
Los Robles Regional Medical Center — Thousand Oaks, California (19.7 mi)
· Sponsor: Medtronic Cardiovascular
A Study to Assess the Efficacy of WSD0922-FU in Patients With C797S+ Advanced Non-small Cell Lung Cancer
Non Small Cell Lung Cancer
Phase 2
Interventional 40 participants sought
FOMAT Oncology — Oxnard, California (0.3 mi)
· Sponsor: Wayshine Biopharm, Inc.
Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
Acute Ischemic Stroke, Cerebral Stroke
Phase 3
Interventional 514 participants sought
St. John's Regional Medical Center — Oxnard, California (0.3 mi)
· Sponsor: Pharmazz, Inc.
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Phase 3
Interventional 762 participants sought
89bio Clinical Study Site — Camarillo, California (8.3 mi)
· Sponsor: 89bio, Inc.
Pan-tumor MRD Study
Muscle Invasive Bladder Urothelial Carcinoma, Esophageal Cancer
N/A
Observational 1,350 participants sought
Ventura County Hematology Oncology Specialists — Oxnard, California (0.3 mi)
· Sponsor: Paradigm Health
Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic Disease Activity
Primary Sjögren's Syndrome
Phase 2
Interventional 180 participants sought
Site Number - 1029 — Thousand Oaks, California (19.7 mi)
· Sponsor: Immunovant Sciences GmbH
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
Acne
Phase 1, Phase 2
Interventional 800 participants sought
Cura Clinical Research - Oxnard- Site Number : 8400062 — Oxnard, California (0.3 mi)
· Sponsor: Sanofi Pasteur, a Sanofi Company
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
HER2-negative Breast Cancer Patients With Brain Metastases
Phase 2
Interventional 120 participants sought
FOMAT Medical Research (Network) — Oxnard, California (0.3 mi)
· Sponsor: Biostar Pharma, Inc.
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
Heart Failure - NYHA II - IV
N/A
Interventional 850 participants sought
Cardiology Associates Medical Group, Inc. — Ventura, California (8.5 mi)
· Sponsor: Boston Scientific Corporation
Non-healing Venous Leg Ulcers Treated With Standard Care With or Without BR-AC
Non-infected Venous Leg Ulcer, Venous Leg Ulcer
N/A
Interventional 60 participants sought
Site 36 — Oxnard, California (0.3 mi)
· Sponsor: BioStem Technologies
Pivotal Study of the Silk Vista Baby Flow Diverters in the Treatment of Unruptured Intracranial Aneurysms (PIONEER)
Intracranial Aneurysm
N/A
Interventional 250 participants sought
Vascular and Neuroscience Institute of Southern California — Thousand Oaks, California (19.7 mi)
· Sponsor: Balt USA
Innoventric Trillium™ Stent Graft Early Feasibility Study (EFS)
Tricuspid Regurgitation, Tricuspid Regurgitation Functional
N/A
Interventional 15 participants sought
Cardiovascular Institute of Los Robles Health System — Thousand Oaks, California (19.7 mi)
· Sponsor: Innoventric LTD
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
Systemic Lupus Erythematosus
Phase 3
Interventional 550 participants sought
Millennium Clinical Trials — Westlake Village, California (21.8 mi)
· Sponsor: Novartis Pharmaceuticals
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Clostridium Difficile, Clostridium Difficile Infections
Phase 3
Interventional 852 participants sought
Clinical Trials Management Services — Thousand Oaks, California (19.7 mi)
· Sponsor: Vedanta Biosciences, Inc.
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Age-related Macular Degeneration (AMD), Geographic Atrophy (GA)
Phase 3
Interventional 975 participants sought
California Retina Consultants — Oxnard, California (0.3 mi)
· Sponsor: Regeneron Pharmaceuticals
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
Coronary Arterial Disease (CAD), de Novo Lesions in Native Coronary Arteries
N/A
Interventional 1,616 participants sought
Los Robles Hospital & Medical Center — Thousand Oaks, California (19.7 mi)
· Sponsor: Boston Scientific Corporation
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Breast Cancer
Phase 3
Interventional 400 participants sought
Rolling Oaks Radiology - Oxnard — Oxnard, California (0.3 mi)
· Sponsor: Pfizer